Compound details
[8]-Dehydrogingerdione
| Compound ID | CDAMM02793 |
|---|---|
| Common name | [8]-Dehydrogingerdione | IUPAC name | 1-(4-hydroxy-3-methoxyphenyl)dodec-1-ene-3,5-dione |
| Molecular formula | C19H26O4 |
| Retention time | 1.08 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 319.187 | Theoretical mz | 319.19 |
| Error | 10.26 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.8963 |
| Inchi key | QOJHXMDTWFYFRL-LUAWRHEFSA-N |
|---|---|
| Smiles | O=C(C=CC1=CC=C(O)C(OC)=C1)CC(=O)CCCCCCC |
| Superclass | Phenylpropanoids and polyketides |
| Class | Cinnamic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P22303 | ACHE | Acetylcholinesterase | T30082 | SEA |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SEA |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P21554 | CNR1 | Cannabinoid receptor 1 (by homology) | T76685 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SEA |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SEA |
| Q9UQL6 | HDAC5 | Histone deacetylase 5 | T07930 | SEA |
| Q8WUI4 | HDAC7 | Histone deacetylase 7 | T98698 | SEA |
| P56524 | HDAC4 | Histone deacetylase 4 | T63816 | SEA |
| Q9UKV0 | HDAC9 | Histone deacetylase 9 | T03687 | SEA |
| P05164 | MPO | Myeloperoxidase | T23471 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SEA |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SEA |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SEA |
| O14684 | PTGES | Prostaglandin E synthase | T02562 | SEA |
| P29350 | PTPN6 | Protein-tyrosine phosphatase 1C | T98264 | SEA |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SEA |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| Q7Z2W7 | TRPM8 | Transient receptor potential cation channel subfamily M member 8 | T41955 | SEA |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SEA |
| P03956 | MMP1 | Matrix metalloproteinase 1 | T52450 | SEA |
| P13726 | F3 | Coagulation factor VII/tissue factor | T72702 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SEA |
| P27695 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | T13348 | SEA |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SEA |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SEA |
| P11388 | TOP2A | DNA topoisomerase II alpha | T17048 | SEA |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SEA |
| Q09472 | EP300 | Histone acetyltransferase p300 | T25956 | SEA |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SEA |
| Q9NR96 | TLR9 | Toll-like receptor (TLR7/TLR9) | T11451 | SEA |
| P34972 | CNR2 | Cannabinoid receptor 2 | T37693 | SEA |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SEA |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| Q13822 | ENPP2 | Autotaxin | T63512 | SEA |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| Q96DB2 | HDAC11 | Histone deacetylase 11 | T97903 | SEA |
| O94759 | TRPM2 | Transient receptor potential cation channel subfamily M member 2 | T78205 | SEA |
| Q969S8 | HDAC10 | Histone deacetylase 10 | T94324 | SEA |
| Q9Y345 | SLC6A5 | Glycine transporter 2 | T58937 | SEA |
| Q9H4B7 | TUBB1 | Tubulin beta-1 chain | T84397 | SEA |
| Q9UJM8 | HAO1 | Hydroxyacid oxidase 1 | T63170 | SEA |
| Q15466 | NR0B2 | Nuclear receptor subfamily 0 group B member 2 | T89859 | SEA |
| P11717 | IGF2R | Insulin-like growth factor II receptor | T59550 | SEA |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| Q9NR20 | DYRK4 | Dual-specificity tyrosine-phosphorylation regulated kinase 4 | T20542 | SEA |
| O75751 | EMTH | Organic cation transporter 3 | T55948 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T63816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P56524 | HDAC4 |
| T23471 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P05164 | MPO |
| T23471 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P05164 | MPO |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T02562 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O14684 | PTGES |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T41955 | DI0422 | Upper respiratory tract disorder | [ICD-11: CA0Z] | Q7Z2W7 | TRPM8 |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T52450 | DI0238 | Lung cancer | [ICD-11: 2C25] | P03956 | MMP1 |
| T72702 | DI0075 | Cervical cancer | [ICD-11: 2C77] | P13726 | F3 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T13348 | DI0365 | Retinopathy | [ICD-11: 9B71] | P27695 | APEX1 |
| T13348 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27695 | APEX1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T17048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11388 | TOP2A |
| T17048 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P11388 | TOP2A |
| T17048 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11388 | TOP2A |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T25956 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q09472 | EP300 |
| T25956 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q09472 | EP300 |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T11451 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9NR96 | TLR9 |
| T11451 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | Q9NR96 | TLR9 |
| T11451 | DI0252 | Melanoma | [ICD-11: 2C30] | Q9NR96 | TLR9 |
| T11451 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q9NR96 | TLR9 |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T63512 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q13822 | ENPP2 |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T94324 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q969S8 | HDAC10 |
| T84397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9H4B7 | TUBB1 |
| T63170 | DI0201 | Inborn carbohydrate metabolism error | [ICD-11: 5C51] | Q9UJM8 | HAO1 |
| T59550 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | P11717 | IGF2R |
| T59550 | DI0368 | Sarcoidosis | [ICD-11: 4B20] | P11717 | IGF2R |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |